Immune Checkpoint Inhibitor–Based Therapy as a Backbone in Cancer Treatment

At JADPRO Live 2019, Krista M. Rubin, MS, FNP-BC, and Anthony J. Olszanski, MD, RPh, reviewed the basic concepts of immunotherapy and the current treatment landscape, and discussed emerging data for immune checkpoint inhibitor–based combinations that are being explored in late-stage clinical trials....

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, Krista M., Olszanski, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2020
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857323/
https://www.ncbi.nlm.nih.gov/pubmed/33598316
http://dx.doi.org/10.6004/jadpro.2020.11.3.3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857323/
https://www.ncbi.nlm.nih.gov/pubmed/33598316
http://dx.doi.org/10.6004/jadpro.2020.11.3.3

Ejemplares similares